162 filings
Page 3 of 9
8-K
VVOS
Vivos Therapeutics Inc
27 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00am
8-K
VVOS
Vivos Therapeutics Inc
2 Mar 23
Vivos Therapeutics Expands Product Line and Revenue Potential with Acquisition of Product Rights and Patents from
9:00am
424B1
VVOS
Vivos Therapeutics Inc
10 Feb 23
Prospectus with pricing info
4:11pm
SC 13G/A
Ronald Kirk Huntsman
10 Feb 23
Vivos Therapeutics / Huntsman Ronald Kirk ownership change
4:05pm
EFFECT
VVOS
Vivos Therapeutics Inc
9 Feb 23
Notice of effectiveness
12:15am
CORRESP
VVOS
Vivos Therapeutics Inc
6 Feb 23
Correspondence with SEC
12:00am
UPLOAD
VVOS
Vivos Therapeutics Inc
3 Feb 23
Letter from SEC
12:00am
S-1
VVOS
Vivos Therapeutics Inc
IPO registration
27 Jan 23
7:52pm
8-K
VVOS
Vivos Therapeutics Inc
9 Jan 23
Vivos Therapeutics Announces Pricing of $8 Million Private Placement
7:30am
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / Anja B Krammer ownership change
9:45pm
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / LEONARD J SOKOLOW ownership change
9:45pm
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / Matthew Thompson ownership change
9:45pm
4
Ronald Kirk Huntsman
28 Dec 22
Vivos Therapeutics / Ronald Kirk Huntsman ownership change
9:45pm
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / Mark F. Lindsay ownership change
9:45pm
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / Bradford K. Amman ownership change
9:45pm
4
VVOS
Vivos Therapeutics Inc
28 Dec 22
Vivos Therapeutics / Ralph Elias Green ownership change
9:45pm
8-K
VVOS
Vivos Therapeutics Inc
20 Dec 22
Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update
4:15pm
10-Q
2022 Q3
VVOS
Vivos Therapeutics Inc
Quarterly report
20 Dec 22
4:11pm
10-Q
2022 Q2
VVOS
Vivos Therapeutics Inc
Quarterly report
20 Dec 22
4:05pm
8-K
VVOS
Vivos Therapeutics Inc
29 Nov 22
Vivos Therapeutics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Third Quarter 2022 Quarterly Report on Form 10-Q
8:00am